Priser
Platform
Blog
Om os
Download
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Hong Kong Stock Exchange
0

Om

Livzon Pharmaceutical Group Co., Ltd. is a prominent player in the biopharmaceutical industry, focusing on the research, development, production, and distribution of pharmaceuticals. The company's primary function is to manufacture a diverse range of drugs, including antibiotics, over-the-counter products, and traditional Chinese medicine formulations. Livzon Pharmaceutical holds a significant position in the healthcare sector by advancing medical treatments and responding to global health demands. This company is particularly noted for its commitment to innovation, reflected in their extensive investment in research and development. Livzon's product portfolio caters to a variety of sectors, from hospitals and clinics to retail pharmacies and international markets. Since its inception, the company has played a vital role in enhancing medical accessibility in China and beyond. Livzon Pharmaceutical Group's impact on the pharmaceutical supply chain underscores its importance in delivering critical healthcare solutions across the globe.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I LIVZON PHARMACEUTICAL GROUP MED ENDAVU: Køb Livzon Pharmaceutical Group ($1513) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Livzon Pharmaceutical Group, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker1513
Land
Kina
Antal medarbejdere8.878
Hjemmesidelivzon.com.cn
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

1,25HKD
'20
1,51HKD
'21
1,51HKD
'22
1,74HKD
'23
1,48HKD
'24
1,2HKD
'25
Ex-udbytte-dato13. jun. 2025
Udbytteafkast4,33%

Analytikerskøn

Baseret på 4 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%50%25%25%0%